Clinical Trial Update: The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

View source ↗

Summary

This completed trial assessed the vascular and metabolic effects of sunitinib in patients with metastatic renal cell carcinoma, focusing on hypertension, renal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Hypertension, Renal Function | Status: COMPLETED